Medigen Vaccine Biologics Corporation (6547.TWO)
TWD 42.7
(6.48%)
TWD 42.7
(6.48%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -991.09 Million TWD | 17.97% |
| 2022 | -1.31 Billion TWD | -186.33% |
| 2021 | 1.52 Billion TWD | 385.44% |
| 2020 | -535.6 Million TWD | -11.56% |
| 2019 | -480.1 Million TWD | -31.54% |
| 2018 | -365 Million TWD | -45.63% |
| 2017 | -250.64 Million TWD | -33.1% |
| 2016 | -188.3 Million TWD | -11.87% |
| 2015 | -168.32 Million TWD | -79.49% |
| 2014 | -93.77 Million TWD | -38.89% |
| 2013 | -67.78 Million TWD | -225.9% |
| 2012 | -20.71 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 31.28 Million TWD | 202.44% |
| 2024 Q1 | -73.23 Million TWD | 94.34% |
| 2024 Q3 | 8.65 Million TWD | -72.35% |
| 2023 Q4 | -512.85 Million TWD | -5232.25% |
| 2023 Q1 | -170.38 Million TWD | 74.78% |
| 2023 Q3 | -9.61 Million TWD | 96.46% |
| 2023 Q2 | -271.35 Million TWD | -59.26% |
| 2023 FY | - TWD | 17.97% |
| 2022 Q4 | -675.59 Million TWD | -152.03% |
| 2022 Q2 | -269.91 Million TWD | -154.09% |
| 2022 Q1 | -106.22 Million TWD | -109.69% |
| 2022 FY | - TWD | -186.33% |
| 2022 Q3 | -268.06 Million TWD | 0.68% |
| 2021 Q2 | -149.07 Million TWD | -16.07% |
| 2021 Q4 | 1.09 Billion TWD | 54.18% |
| 2021 Q1 | -128.43 Million TWD | 15.07% |
| 2021 FY | - TWD | 385.44% |
| 2021 Q3 | 710.65 Million TWD | 576.7% |
| 2020 Q3 | -148.1 Million TWD | -6.61% |
| 2020 FY | - TWD | -11.56% |
| 2020 Q2 | -138.93 Million TWD | -42.73% |
| 2020 Q1 | -97.33 Million TWD | 37.82% |
| 2020 Q4 | -151.23 Million TWD | -2.11% |
| 2019 Q3 | -90.91 Million TWD | 29.16% |
| 2019 FY | - TWD | -31.54% |
| 2019 Q4 | -156.54 Million TWD | -72.2% |
| 2019 Q2 | -128.33 Million TWD | -23.02% |
| 2019 Q1 | -104.31 Million TWD | 22.95% |
| 2018 Q4 | -135.38 Million TWD | -107.87% |
| 2018 FY | - TWD | -45.63% |
| 2018 Q2 | -102.99 Million TWD | -67.48% |
| 2018 Q1 | -61.49 Million TWD | 27.92% |
| 2018 Q3 | -65.12 Million TWD | 36.76% |
| 2017 FY | - TWD | -33.1% |
| 2017 Q4 | -85.31 Million TWD | -54.71% |
| 2017 Q2 | -60.02 Million TWD | -19.66% |
| 2017 Q3 | -55.14 Million TWD | 8.13% |
| 2017 Q1 | -50.16 Million TWD | 38.65% |
| 2016 Q4 | -81.76 Million TWD | -210.77% |
| 2016 Q3 | -26.3 Million TWD | 36.48% |
| 2016 Q1 | -41.41 Million TWD | -4.39% |
| 2016 Q2 | -41.41 Million TWD | 0.0% |
| 2016 FY | - TWD | -11.87% |
| 2015 Q3 | -39.67 Million TWD | 13.14% |
| 2015 Q1 | -45.67 Million TWD | -80.14% |
| 2015 Q2 | -45.67 Million TWD | 0.0% |
| 2015 FY | - TWD | -79.49% |
| 2015 Q4 | -39.67 Million TWD | 0.0% |
| 2014 FY | - TWD | -38.89% |
| 2014 Q4 | -25.35 Million TWD | 0.0% |
| 2014 Q3 | -25.35 Million TWD | -10.0% |
| 2014 Q2 | -23.05 Million TWD | 0.0% |
| 2014 Q1 | -23.05 Million TWD | 0.0% |
| 2013 FY | - TWD | -225.9% |
| 2012 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Sagittarius Life Science Corp | -44.73 Million TWD | -2115.277% |
| Neith Corporation | -33.61 Million TWD | -2848.804% |
| TaiRx, Inc. | -208.64 Million TWD | -375.012% |
| BioGend Therapeutics Co., Ltd. | -113.1 Million TWD | -776.251% |
| Shine-On BioMedical Co.,Ltd. | -33 Million TWD | -2902.766% |
| Great Novel Therapeutics Biotech & Medicals | -54.91 Million TWD | -1704.776% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 393.6 Million TWD | 351.799% |
| NeoCore Technology Co., Ltd. | -72.11 Million TWD | -1274.323% |
| GeneReach Biotechnology Corp. | -143.69 Million TWD | -589.72% |
| Genomics BioSci & Tech. Co.,Ltd. | -103.61 Million TWD | -856.515% |
| Visgeneer Inc. | 973 Thousand TWD | 101959.507% |
| Sunmax Biotechnology Co., Ltd. | 936.46 Million TWD | 205.833% |
| G&E Herbal Biotechnology Co., Ltd. | 99.83 Million TWD | 1092.711% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -1.73 Million TWD | -56957.743% |
| Enimmune corporation | -228.96 Million TWD | -332.862% |
| EirGenix Inc. | -664.4 Million TWD | -49.17% |
| BioLASCO Taiwan Co., Ltd. | 73.9 Million TWD | 1441.055% |
| Sunny Pharmtech Inc. | 69.14 Million TWD | 1533.396% |
| Feng Chi Biotech Corp. | 34.83 Million TWD | 2944.862% |
| Lukas Biomedical Inc. | -26.3 Million TWD | -3668.414% |
| RBC Bioscience Corporation | 36.54 Million TWD | 2811.831% |
| BiOptic Inc. | 65.03 Million TWD | 1623.868% |
| Anti-Microbial Savior BioteQ Co., Ltd | -46.24 Million TWD | -2043.182% |
| Syngen Biotech Co.,Ltd. | 433.55 Million TWD | 328.596% |
| Mycenax Biotech Inc. | -339.48 Million TWD | -191.942% |
| Bio Preventive Medicine Corp. | -62.34 Million TWD | -1489.793% |
| Level Biotechnology Inc. | 98.7 Million TWD | 1104.106% |
| TaiMed Biologics Inc. | -25.23 Million TWD | -3827.765% |
| GlycoNex Incorporation | -126.82 Million TWD | -681.453% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 21.81 Million TWD | 4644.214% |
| SynCore Biotechnology Co.,Ltd | -17.72 Million TWD | -5491.182% |
| Lin BioScience, Inc. | -1.07 Billion TWD | 7.496% |
| BRIM Biotechnology, Inc. | -682.46 Million TWD | -45.223% |
| VBI | -6.97 Million TWD | -14115.333% |
| CHO Pharma, Inc. | -277.73 Million TWD | -256.854% |
| Advagene Biopharma Co., Ltd. | -80.07 Million TWD | -1137.752% |
| NaviFUS Corp. | -55.79 Million TWD | -1676.311% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -16.59 Million TWD | -5871.159% |
| Sinew Pharma Inc. | -163.63 Million TWD | -505.688% |
| Andros Pharmaceuticals Co.,Ltd | -61.5 Million TWD | -1511.533% |
| Greenyn Biotechnology Co., Ltd | 192.4 Million TWD | 615.116% |
| Lumosa Therapeutics Co., Ltd. | -226.67 Million TWD | -337.225% |
| AP Biosciences Inc | -325.51 Million TWD | -204.471% |
| Medigen Biotechnology Corp. | -1.04 Billion TWD | 5.124% |
| 3D Global Biotech Inc. | -35.84 Million TWD | -2664.864% |
| Pharmosa Biopharm Inc. | 29.13 Million TWD | 3502.31% |
| Intech Biopharm Corporation | -219.58 Million TWD | -351.348% |
| Oneness Biotech Co., Ltd. | -674.22 Million TWD | -46.996% |
| Eusol Biotech Co.,Ltd. | -44.95 Million TWD | -2104.83% |
| TWi Biotechnology, Inc. | -160.85 Million TWD | -516.133% |
| Ever Supreme Bio Technology Co., Ltd | 655.52 Million TWD | 251.191% |
| TCI GENE Inc. | 25.98 Million TWD | 3914.684% |
| MegaPro Biomedical Co., Ltd | -110.63 Million TWD | -795.798% |
| Senhwa Biosciences, Inc. | -283.78 Million TWD | -249.241% |
| Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | -578.97% |
| NatureWise Biotech & Medicals Corporation | 13.85 Million TWD | 7255.906% |
| PharmaEngine, Inc. | 347.3 Million TWD | 385.366% |
| Savior Lifetec Corporation | 219.6 Million TWD | 551.307% |
| TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | 675.447% |
| OBI Pharma, Inc. | -855.08 Million TWD | -15.906% |
| Meribank Biotech Co., Ltd | -92.56 Million TWD | -970.723% |
| Acepodia, Inc. | -764.51 Million TWD | -29.636% |
| Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | -115.413% |